Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1174-1179
Published online before print April 14, 2005, doi: 10.1161/01.ATV.0000166516.52477.81
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/6/1174    most recent
01.ATV.0000166516.52477.81v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heitzer, T.
Right arrow Articles by Meinertz, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heitzer, T.
Right arrow Articles by Meinertz, T.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1174.)
© 2005 American Heart Association, Inc.


Vascular Biology

Systemic Endothelial Dysfunction as an Early Predictor of Adverse Outcome in Heart Failure

Thomas Heitzer; Stephan Baldus; Yskert von Kodolitsch; Volker Rudolph; Thomas Meinertz

From Universitäres Herzzentrum, Medizinische Klinik III, Hamburg, Germany.

Correspondence to Dr Thomas Heitzer, Universitäres Herzzentrum, Medizinische Klinik III, Martinistr. 52, 20246 Hamburg, Germany. E-mail heitzer{at}uke.uni-hamburg.de

Objective— Endothelial dysfunction is an early event in the natural progression of heart failure. Increased oxidative stress has been linked to impaired endothelial function and both may play a prognostic role.

Methods and Results— Endothelium-dependent and endothelium-independent vasodilatation were determined in 289 patients with mild left ventricular dysfunction by measuring forearm blood flow responses to acetylcholine and sodium nitroprusside using venous occlusion plethysmography. Vascular effects of the coadministration of the antioxidant vitamin C at pharmacological doses (24 mg/min) were assessed. Occurrence of death, heart transplantation, and readmission with worsening heart failure were recorded as clinical outcome parameters during a follow-up period of 4.8 years. Patients experiencing adverse events (n=79) had lower vasodilator responses to acetylcholine (P<0.001) and to sodium nitroprusside (P=0.03) compared with patients without events. However, beneficial effects of vitamin C did not differ between both groups. Cox proportional hazards model demonstrated that age (P=0.001), renal function (P=0.001), and blunted acetylcholine-induced vasodilatation (P=0.007) remained independent predictors of adverse outcome.

Conclusions— Impaired peripheral endothelial function independently predicts long-term adverse outcome in patients with early-stage heart failure. The findings suggest that assessment of peripheral endothelial function may represent an additional mean for risk stratification and therapy management in these patients.

Endothelium-dependent and endothelium-independent vasodilatation was assessed in 289 patients with mild heart failure by measuring forearm blood flow with and without vitamin C administered at pharmacological doses using venous occlusion plethysmography. During follow-up, patients experiencing adverse events had lower vasodilator responses to acetylcholine and sodium nitroprusside, but similar beneficial effects of vitamin C.


Key Words: endothelium • free radicals • heart failure • nitric oxide • prognosis




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. R. Pries, H. Habazettl, G. Ambrosio, P. R. Hansen, J. C. Kaski, V. Schachinger, H. Tillmanns, G. Vassalli, I. Tritto, M. Weis, et al.
A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings
Cardiovasc Res, June 25, 2008; (2008) cvn136v2.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Dworakowski, S. Walker, A. Momin, J. Desai, A. El-Gamel, O. Wendler, M. T. Kearney, and A. M. Shah
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Derived Superoxide and Vascular Endothelial Dysfunction in Human Heart Failure
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1349 - 1356.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Briet, C. Collin, S. Laurent, A. Tan, M. Azizi, M. Agharazii, X. Jeunemaitre, F. Alhenc-Gelas, and P. Boutouyrie
Endothelial Function and Chronic Exposure to Air Pollution in Normal Male Subjects
Hypertension, November 1, 2007; 50(5): 970 - 976.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Mittermayer, G. Schaller, J. Pleiner, K. Krzyzanowska, S. Kapiotis, M. Roden, and M. Wolzt
Rosiglitazone Prevents Free Fatty Acid-Induced Vascular Endothelial Dysfunction
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2574 - 2580.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Iwasaki, K. Fukushima, A. Kawamoto, K. Umetani, A. Oyamada, S. Hayashi, T. Matsumoto, M. Ishikawa, T. Shibata, H. Nishimura, et al.
Synchrotron Radiation Coronary Microangiography for Morphometric and Physiological Evaluation of Myocardial Neovascularization Induced by Endothelial Progenitor Cell Transplantation
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1326 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
I. H. Zucker, H. D. Schultz, W. Wang, M. Guazzi, A. C. Scott, C. E. Negrao, M. U. P. B. Rondon, E. S. Prakash, A. L. Clark, A. Crisafulli, et al.
Increased mechanoreceptor/metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure
J Appl Physiol, January 1, 2007; 102(1): 498 - 501.
[Full Text] [PDF]


Home page
CirculationHome page
J. George, E. Carr, J. Davies, J.J.F. Belch, and A. Struthers
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
Circulation, December 5, 2006; 114(23): 2508 - 2516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Feletou and P. M. Vanhoutte
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Iida, Y. Chu, R. M. Weiss, Y. M. Kang, F. M. Faraci, and D. D. Heistad
Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H914 - H920.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Baldus, V. Rudolph, M. Roiss, W. D. Ito, T. K. Rudolph, J. P. Eiserich, K. Sydow, D. Lau, K. Szocs, A. Klinke, et al.
Heparins Increase Endothelial Nitric Oxide Bioavailability by Liberating Vessel-Immobilized Myeloperoxidase
Circulation, April 18, 2006; 113(15): 1871 - 1878.
[Abstract] [Full Text] [PDF]